Ulnar nerve abscess and relapse in a patient with indeterminate leprosy 1 year after completion of multidrug therapy.
The introduction of multidrug therapy has efficiently controlled leprosy in developing countries. However, Mycobacterium laprae may survive and cause relapse despite adequate treatment with antileprosy drugs. Relapse may be characterized by a combination of new signs or symptoms and presence of acid-fast bacilli on skin or nerve biopsy samples. We report a case of a child in whom ulnar abscess developed 12 months after successful completion of multidrug therapy with clinical and histopathological evidence of relapse.
Agrawal
Amit
A
Department of Neurosurgery, K.S. Hegde Medical Academy, Mangalore, India. dramit_in@yahoo.com
Dalal
Monica
M
Makkannavar
J H
JH
Shetty
J P
JP
D000038:Abscess / Q000382:microbiology* / Q000628:therapy; D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012008:Recurrence; D014459:Ulnar Nerve / Q000382:microbiology* / Q000601:surgery
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D007917:Leprostatic Agents; D011239:Prednisolone